SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-029490
Filing Date
2022-08-15
Accepted
2022-08-15 16:21:28
Documents
88
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q txmd-10q_20220630.htm   iXBRL 10-Q 2393989
2 EX-31.1 txmd-ex311_10.htm EX-31.1 18319
3 EX-31.2 txmd-ex312_8.htm EX-31.2 18812
4 EX-32.1 txmd-ex321_6.htm EX-32.1 8106
5 EX-32.2 txmd-ex322_9.htm EX-32.2 8344
6 GRAPHIC g1xkrg0p0glu000001.jpg GRAPHIC 4411
  Complete submission text file 0001564590-22-029490.txt   10203687

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA txmd-20220630.xsd EX-101.SCH 75433
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE txmd-20220630_cal.xml EX-101.CAL 56942
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE txmd-20220630_def.xml EX-101.DEF 234760
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20220630_lab.xml EX-101.LAB 469398
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20220630_pre.xml EX-101.PRE 405044
82 EXTRACTED XBRL INSTANCE DOCUMENT txmd-10q_20220630_htm.xml XML 2241768
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-00100 | Film No.: 221165926
SIC: 2834 Pharmaceutical Preparations